A recent update to a popular app used by people with diabetes has caused it to stop working on some Apple devices, leaving users without their usual method of checking blood sugar levels. The app is connected to the FreeStyle Libre device manufactured by Abbott, which is the leading sensor-based glucose monitoring system worldwide.
The issue has resulted in the withdrawal of the app from the App Store after it ceased functioning on certain Apple devices. The FreeStyle Libre device includes a small sensor inserted into the user’s body, which sends data to the app for monitoring purposes. In the UK alone, approximately 200,000 people rely on these types of sensors for managing their diabetes.
Abbott has confirmed that the problem is only affecting customers in the UK and expects the app to be made available again soon. However, there has been a strong backlash from individuals who depend on the technology for their well-being. Many have expressed their concerns online, highlighting the impact of not being able to use the app for continuous glucose monitoring.
People with type 1 diabetes rely on CGMs to monitor their blood glucose levels
The LibreLink app, developed by Abbott, connects to a continuous glucose monitor (CGM) through a white disc attached to a needle inserted under the user’s skin, typically in the arm or belly. People with type 1 diabetes rely on CGMs to monitor their blood glucose levels continuously, eliminating the need for frequent finger pricks. Real-time monitoring enables users to make informed decisions regarding food intake and exercise, while also providing alerts for abnormal blood sugar levels.
Abbott is actively working to address the issue and restore access to the app for affected users in the UK.